Abstract
Synthesis and preliminary in vitro biological evaluation of a selective high-affinity CRTH2 antagonist is described. The stability of an N-benzyl group facilitated synthesis of the corresponding radioligand by tritiation of a brominated precursor. The compound [(3)H]TRQ11238 represents the first selective CRTH2 antagonist radioligand and exhibited a specific radioactivity of 52 Ci/mmol and a pK(d) of 9.0 Udgivelsesdato: 2007-Nov-1
Originalsprog | Engelsk |
---|---|
Tidsskrift | Bioorganic & Medicinal Chemistry Letters |
Vol/bind | 17 |
Udgave nummer | 21 |
Sider (fra-til) | 5924-5927 |
Antal sider | 4 |
ISSN | 0960-894X |
DOI | |
Status | Udgivet - 1 nov. 2007 |